These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33462559)

  • 1. China health technology and stringency containment measures during COVID-19 pandemic: A discussion of first and second wave of COVID-19.
    Abbas HSM; Xu X; Sun C
    Health Technol (Berl); 2021; 11(2):405-410. PubMed ID: 33462559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development, Status Quo, and Challenges to China's Health Informatization During COVID-19: Evaluation and Recommendations.
    Huang M; Wang J; Nicholas S; Maitland E; Guo Z
    J Med Internet Res; 2021 Jun; 23(6):e27345. PubMed ID: 34061761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. China's Public Health Policies in Response to COVID-19: From an "Authoritarian" Perspective.
    Gao J; Zhang P
    Front Public Health; 2021; 9():756677. PubMed ID: 34976920
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19 pandemic, government response, and policy implications in China, India, Iran, and Pakistan (CIIP).
    Abbas HSM; Xu X; Sun C
    J Emerg Manag; 2021 Special Issue on COVID-19; 18(7):49-61. PubMed ID: 34723347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 Containment Measures-a Step Back for Walking Mobility? A 2-Year, 60-Country Analysis of the Apple Mobility Data.
    Luciano F; Crova F; Canella F
    J Phys Act Health; 2023 May; 20(5):394-401. PubMed ID: 36972703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Persistence and Change in China's Healthcare Insurance Reform: Clues from Fiscal Subsidy Policies Made for Settling COVID-19 Patients' Medical Costs.
    Ma T; Guo B; Xu J
    Risk Manag Healthc Policy; 2022; 15():1129-1144. PubMed ID: 35637742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of China's public health system response to COVID-19.
    Zhang P; Gao J
    J Glob Health; 2021 Jan; 11():05004. PubMed ID: 33643637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International Trade of Masks and COVID-19 Pandemic Containment.
    Fan X; Li B; Xiu Y
    J Environ Public Health; 2022; 2022():2156950. PubMed ID: 35855816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of China's Legal System on Public Health and Quality of Life during the COVID-19 Pandemic: An Empirical Study.
    Duan W; Qin T
    Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36294176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research on the Integration of Cultural Tourism Industry Driven by Digital Economy in the Context of COVID-19-Based on the Data of 31 Chinese Provinces.
    Li X; Liang X; Yu T; Ruan S; Fan R
    Front Public Health; 2022; 10():780476. PubMed ID: 35356017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review and challenges of policies of environmental protection and sustainable development in China.
    Zhang KM; Wen ZG
    J Environ Manage; 2008 Sep; 88(4):1249-61. PubMed ID: 17767999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From SARS to the Omicron variant of COVID-19: China's policy adjustments and changes to prevent and control infectious diseases.
    Luo M; Liu Q; Wang J; Gong Z
    Biosci Trends; 2022 Jan; 15(6):418-423. PubMed ID: 34924490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on the Experience of Public Health System Construction in China's COVID-19 Prevention.
    Zhang P
    Front Public Health; 2021; 9():610824. PubMed ID: 33981659
    [No Abstract]   [Full Text] [Related]  

  • 14. Expanding public health in China: an empirical analysis of healthcare inputs and outputs.
    Deng F; Lv JH; Wang HL; Gao JM; Zhou ZL
    Public Health; 2017 Jan; 142():73-84. PubMed ID: 28057203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appraisal of China's Response to the Outbreak of COVID-19 in Comparison With SARS.
    Li J; Li S; Cao W; Wang Z; Liang Z; Fu W; Zhao J
    Front Public Health; 2021; 9():679540. PubMed ID: 34307279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stringent containment measures without complete city lockdown to achieve low incidence and mortality across two waves of COVID-19 in Hong Kong.
    Wong MCS; Ng RWY; Chong KC; Lai CKC; Huang J; Chen Z; Boon SS; Chan PKS
    BMJ Glob Health; 2020 Oct; 5(10):. PubMed ID: 33028700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic Use in China's Public Healthcare Institutions During the COVID-19 Pandemic: An Analysis of Nationwide Procurement Data, 2018-2020.
    Yang Y; Geng X; Liu X; Wen X; Wu R; Cui D; Mao Z
    Front Pharmacol; 2022; 13():813213. PubMed ID: 35237164
    [No Abstract]   [Full Text] [Related]  

  • 18. Policy Stringency, Handwashing and COVID-19 cases: Evidence from Global dataset.
    Dzator J; Acheampong AO; Dzator M; Paolucci F; Yawe BL; Asmah EE; Andoh FK; Kabagenyi A; Gillespie J
    Health Policy Technol; 2022 Jun; 11(2):100574. PubMed ID: 34786329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public Health Crises In Comparison: China's Epidemic Response Policies From SARS To COVID-19.
    Li M
    Glob Public Health; 2021; 16(8-9):1223-1236. PubMed ID: 33891518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical Insurance Information Systems in China: Mixed Methods Study.
    Li Y; Lu C; Liu Y
    JMIR Med Inform; 2020 Sep; 8(9):e18780. PubMed ID: 32673209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.